Indeed, blocking Wnt/β-catenin signaling amplified anti-PD-1 therapeutic efficacy by inhibiting tumor growth, migration, and promoting immune infiltration in glioblastomas [33]. This evidence concerns the gene PDCD1 and glioblastoma.